Evidence map›Paper›PMID 40502747›Full record

ArticleResearch square2025

Identification of cross-stage, cross-species malaria CD8

Camila R R Barbosa, Luna B de Lacerda, Paulo Bettencourt, David Morrow, Dhelio B Pereira, Maya Aleshnick, Julie Mitchell, Zezhou Zhao, Cristopher Gomes, Guilherme C Maia and 17 more

Abstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in Research square, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

27 authors.

Camila R R BarbosaInstituto René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, MG 30190-002, Brazil.
Luna B de LacerdaInstituto René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, MG 30190-002, Brazil.ORCID 0000-0003-1577-348X
Paulo BettencourtThe Jenner Institute, University of Oxford, Oxford OX3 7DQ, UK.ORCID 0000-0002-4884-5470
David MorrowVaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006, USA.ORCID 0000-0003-4686-830X
Dhelio B PereiraCentro de Pesquisas em Medicina Tropical de Rondônia, Porto Velho, RO 78909-350, Brazil.ORCID 0000-0002-7761-5498
Maya AleshnickVaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006, USA.
Julie MitchellVaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006, USA.ORCID 0000-0001-7400-7027
Zezhou ZhaoRagon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA.
Cristopher GomesInstituto René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, MG 30190-002, Brazil.
Guilherme C MaiaInstituto René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, MG 30190-002, Brazil.
Gregório G AlmeidaInstituto René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, MG 30190-002, Brazil.
Camila M CostaInstituto René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, MG 30190-002, Brazil.
Annalisa NicastriThe Jenner Institute, University of Oxford, Oxford OX3 7DQ, UK.
Marie Rose SchrimpfProgram in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115, USA.ORCID 0009-0005-8272-0953
Roxanne BeebeVaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006, USA.
John B SchellVaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006, USA.
Payton KirtleyVaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006, USA.
Lis AntonelliInstituto René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, MG 30190-002, Brazil.
Gaurav Das GaihaRagon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA.ORCID 0000-0001-6875-4472
Scott HansenVaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006, USA.
Klaus FruehVaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006, USA.ORCID 0000-0001-8014-3877
Judy LiebermanProgram in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115, USA.ORCID 0000-0002-6200-4715
Ricardo T GazzinelliInstituto René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, MG 30190-002, Brazil.
Nicola TernetteThe Jenner Institute, University of Oxford, Oxford OX3 7DQ, UK.ORCID 0000-0002-9283-0743
Brandon WilderVaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006, USA.
Adrian V S HillThe Jenner Institute, University of Oxford, Oxford OX3 7DQ, UK.ORCID 0000-0003-0900-9629
Caroline JunqueiraInstituto René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, MG 30190-002, Brazil.ORCID 0000-0003-0545-0986

Funding

Sugar-feeding behavior of the malaria vector Nyssorhynchus darlingi and development of effective attractive toxic sugar baits (ATSB) to increase intervention success in PeruU19AI089681 · NIAID · YALE UNIVERSITY · PI FERREIRA, MARCELO URBANO · 2010 to 2023
$20.1M
Integrating human and non-human primate data to understand the acquisition of pre-erythrocytic immunity in the face of previous malaria exposureU01AI165457 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI Sean C Murphy, Brandon Keith Wilder · 2022 to 2026
$5.1M
NIAID NIH HHS U01 AI165457NIAID NIH HHS U19 AI089681
6 · The paper itself

Abstract

Malaria is one of the most prevalent parasitic diseases in the world. In 2023, 263 million malaria cases were estimated worldwide

Identifiers

PMID40502747
PMCPMC12154130

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.